TrialEuropean journal of clinical pharmacology2025

Therapeutic impact of vildagliptin vs. gliclazide on insulin resistance and advanced glycated end product levels in newly diagnosed Egyptian diabetics: a randomized controlled trial.

Toka Elemary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.